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An outbreak of aseptic meningitis occurred in the
northern area of Jiangsu Province in China from January to
July in 2003. A total of 1,681 cases were involved in this
outbreak, and 99% of patients were <15 years of age. To
identify the etiologic agent, 66 cerebrospinal fluid speci-
mens were tested by cell culture. Eighteen showed an
enteroviruslike cytopathic effect on MRC-5 human fetal
diploid lung cells. An enterovirus primer-mediated reverse
transcriptase–polymerase chain reaction, a standard neu-
tralization assay, and sequencing of the complete capsid-
encoding (VP1) gene identified the 18 isolates (FDJS03) as
echovirus 30. At least a 10% difference was seen in
nucleotide sequences of VP1 between FDJS03 isolates
and other global strains of echovirus 30. Phylogenetic
analysis based on complete sequences of VP1 was per-
formed to further characterize the FDJS03 isolates. This
report is the first to identify a distinct lineage of echovirus
30 as a probable cause of this outbreak.
E
nteroviruses circulate worldwide and are the most com-
monly identified cause of aseptic meningitis, particu-
larly in infants and young children; 30,000–50,000 persons
per year are hospitalized with aseptic meningitis in the
United States (1). During the past decade, numerous out-
breaks of enteroviral meningitis were documented through-
out the world (2–5). In China, infections with other
enteroviruses are reported more frequently because wild-
type polioviruses were eradicated by the expanded immu-
nization program in 1992. Outbreaks associated with
nonpolio enteroviruses have been sequentially reported in
recent years (6–8). Specific serotypes of etiologic agents
were not identified in outbreaks involving nonpolio
enteroviruses in China, since serotyping usually had no
influence on clinical management of a given patient with an
enteroviral infection. However, identification of the
serotype and the molecular characteristics of the prevailing
virus can provide valuable epidemiologic information in
outbreak investigations. The serotype-specific immune sta-
tus of the population, territorial competition among
serotypes, and transmission efficiency of the virus may also
be important factors influencing epidemiologic behavior of
human enteroviruses (HEV) (9,10). An understanding of
circulating virus strains in local regions would be essential
in effectively controlling enteroviral infections.
An unusual outbreak of aseptic meningitis in 1,681
patients occurred in the northern area of Jiangsu Province
in China from January to July in 2003. In this report, we
provide evidence for a distinct lineage of echovirus 30 as
the etiologic agent of this outbreak.
Materials and Methods
Specimen Collection  
Lumbar puncture on admission was used to obtain 204
cerebrospinal fluid (CSF) specimens from 204 hospital-
ized patients in prefectural hospitals in whom aseptic
meningitis had been diagnosed. After culturing for bacter-
ial growth, 66 CSF specimens were available for virus iso-
lation on 3 cell lines. All CSF specimens (≈2 mL per
sample) were sent to our laboratory in sterile containers at
4°C, separated into aliquots, and stored at –80°C for fur-
ther study.
Cell Culture and Virus Isolation  
Human fetal diploid lung (MRC-5), buffalo green mon-
key kidney (Vero), and human epidermoid carcinoma
(HEp2) cells were used in the study. Cells were grown in
minimal essential medium (MEM) supplemented with
10% newborn calf serum, 50 U/mL of penicillin, and 50
µg/mL of streptomycin. Viruses were isolated from the
original clinical specimens and propagated in cell culture
by standard methods (11). Briefly, 200 µL of each CSF
specimen was added in duplicate into 24-well plates cov-
ered with monolayers of each cell culture. Maintenance
medium (MEM plus 2% newborn calf serum) was then
added to each well. All cultures were incubated at 37°C in
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for an enteroviruslike cytopathic effect (CPE). In cultures
exhibiting no CPE by the end of observation period, blind
passage was performed for another 7 days. Passage was
performed twice before the culture was reported as nega-
tive. Cultures showing an enteroviruslike CPE were passed
once more for confirmation. The primary identification of
positive isolates as enterovirus was done by a reverse tran-
scriptase-polymerase chain reaction (RT-PCR) with 2 pairs
of enterovirus general primers (12–14), which detect near-
ly all types of enterovirus (12,15). The reference
enterovirus strain used in this study was coxsackievirus
B1. Positive isolates were designated Echo30-FDJS03,
which was abbreviated as FDJS03.
Neutralization Assays with an Antibody Pool
Serotype identification was performed by neutraliza-
tion with an antibody pool for enterovirus (Kunming
Medical Biology Institute, Kunming, China) and 11 other
type-specific monoclonal antibodies (Kunming Medical
Biology Institute) not included in the antibody pool. Each
positive strain was tested by a neutralization assay, accord-
ing to standard procedures(16), and viral titers were simul-
taneously determined.
Extraction of Viral RNA
Viral RNA was extracted from 200 µL of positive cul-
ture supernatants by using RNAex reagent (Huashun Co.,
Shanghai, China), according to the manufacturer’s instruc-
tions, and diluted in 20 µL of diethylpyrocarbonate-treated
sterile distilled water. The viral RNA solution was used
immediately or stored at –80oC until analysis by RT-PCR.
A standard reference virus strain and a normal cell culture
supernatant were used as positive and negative controls,
respectively.
RT-PCR and Sequencing of DNA
A 2-step RT-PCR was used. Synthesis of cDNA was
done in a 20-µL reaction volume containing 2 mmol/L
deoxynucleotide triphosphates, 20 U of RNAsin
(Promega, Madison, WI, USA), 10 pmol of random hexa-
mer, 200 U of Moloney murine leukemia virus reverse
transcriptase (Promega), 4 µLof 5× RT buffer, and 5 µLof
extracted RNA. The mixture was incubated at 37°C for 60
min and inactivated at 95°C for 5 min. 
The highly conserved 5′ untranslated region (UTR) was
used to detect enterovirus by PCR amplification (17). Two
sets of amplification primers (12–14), UG52 (sense, 5′-
CAAGCACTTCTGTTTCCCCGG-3′, nucleotides [nt]
168–188, Bastianni) and primer 2 (sense, 5′-TCCTCCG-
GCCCCTGAATGCG-3′, nt 445–464, coxsackie B1) (12),
and a common antisense primer (UC53 5′-TTGTCAC-
CATAACCAGCCA-3′, nt 588–606, Bastianni) were used
to produce PCR products of 440 (UG52/UC53) and 155
(primer2/UC53) bp, respectively. The PCR protocol con-
sisted of denaturation at 94°C for 5 min; extension for 35
cycles at 94°C for 45 s, 52°C for 45 s, and 72°C for 45 s;
and final extension at 72°C for 7 min. 
The capsid-encoding VP3 and VP1 genes and the 2A
gene of enterovirus were amplified with PCR primers 008
(sense, 5′-GCRTGCAATGAYTTCTCWGT-3′, nt
2411–2430, PV1-Mahoney) and 011 (antisense, 5′-GCIC-
CIGAYTGITGICCRAA-3′, nt 3408–3389, PV1-
Mahoney) (9). PCR amplification was done for 35 cycles
at 94°C for 30 s, 51°C for 30 s, and 72°C for 30 s. The RT-
PCR products were analyzed by electrophoresis on 2%
agarose gels containing 0.5 µg/mL of ethidium bromide,
and purified by using a gel extraction kit (Bioasia Co.,
Shanghai, China). 
DNA sequencing was performed by using an automat-
ed DNA sequencer (ABI 3730, Applied Biosytems, Foster
City, CA, USA). Each RT-PCR product was sequenced in
both directions to resolve possible ambiguous nucleotides.
Sequence Analysis  
The serotypes of the viral isolates were determined by
comparing their complete VP1 sequences with those avail-
able in the GenBank database. Nucleotide sequence
homology was inferred by the identity scores obtained
with the BLASTn program (National Center for
Biotechnology Information, Bethesda, MD, USA). The
pairwise sequence identities of the nucleotide and deduced
amino acid sequences among FDJS03 isolates and other
serotypes were calculated with the program Omiga 2.0
(Oxford Molecular Ltd., Madison, WI, USA). Four iso-
lates randomly sampled from the 18 positive strains were
used for phylogenetic analysis. Multiple-sequence align-
ments were done with ClustalX 1.83 (European Molecular
Biology Laboratory, Heidelberg, Germany), and 2 meth-
ods (neighbor-joining and maximum parsimony) of phylo-
genetic analysis were used to provide a more reliable
inference of phylogeny. A neighbor-joining tree was con-
structed with TREE-PUZZLE 5.0 (Deutsches Krebs-
forschungszentrum, Heidelberg, Germany) and the
Dnapars program in software package PHYLIP 3.573c
(University of Washington, Seattle, WA, USA) was used
for maximum parsimony analysis. The statistical signifi-
cance of phylogenetic trees constructed with Neighbor and
Dnapars in PHYLIP 3.573c was estimated by bootstrap
analysis with 100 pseudoreplicate data sets. The final con-
sensus tree was produced with the Consense program in
PHYLIP 3.573c. Treeview 1.6.6 (University of Glasgow,
Glasgow, United Kingdom) was used to edit phylogenetic
trees. The echovirus 30 sequences reported have been
deposited in the GenBank database under accession nos.
AY665606–AY665609.
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An outbreak of aseptic meningitis in 1,681 patients
occurred in the northern area of Jiangsu Province in China
from January to July 2003. Most (99%) patients in this out-
break were children <15 years of age. Boys were nearly
twice as likely as girls to have aseptic meningitis (ratio
1,145:536). Fever, headache, and vomiting were the most
common clinical manifestations, and 204 CSF cultures
were negative for bacterial growth. The epidemic was dis-
tributed in both urban and rural areas. The peak period was
from March to June, 2003, when 1,565 cases occurred,
which accounted for 93.1% of all patients.
To investigate the primary etiologic agent in this out-
break, CSF specimens were used for virus isolation and
identification. Sixty-six CSF specimens from 66 aseptic
meningitis patients were tested by cell culture, and 18
showed positive results (isolation rate 27.3%). An
enteroviruslike CPE (data not shown) was observed in
MRC-5 cells infected with these isolated strains, but not in
Vero and HEp2 cells. Most positive isolates showed a CPE
as early as 3–5 days postinoculation. The exception was 1
isolate that did not show any CPE until the third day of the
second blind passage. For FDJS03 isolates, typical picor-
navirus particles (round, nonstructured virus particles ≈30
nm in diameter) were observed by negative staining and
electron microscopy (data not shown). All 18 positive iso-
lates were successfully amplified by RT-PCR with primers
specific for enterovirus sequences to yield predicted prod-
ucts of 440 bp and 155 bp (data not shown).  Specific
serotype identification was performed with a standard
microneutralization test, but it did not show neutralization
of any strains with the antibody pool. This finding prompt-
ed serotype identification with additional monoclonal anti-
bodies not present in the pool. The isolates were totally
neutralized by monoclonal antibody to echovirus 30, and
the other antibodies did not show neutralization. This find-
ing suggests that all 18 positive strains were echovirus 30.
After the complete VP1-encoding genes of 4 randomly
sampled isolates were sequenced, molecular identification
of the isolates by comparison with corresponding
sequences of HEV in GeneBank confirmed the results of
neutralization assays. The percentage identity was calcu-
lated by pairwise comparisons of aligned nucleotide and
amino acid sequences (Table). Among 4 FDJS03 isolates,
99% sequence identity was seen at both nucleotide and
amino acid levels. HEV can be clustered into 4 species
(HEV-A, HEV-B, HEV-C, and HEV-D) based on genetic
relationships of the capsid-encoding region VP1 (1). The
nucleotide and amino acid VP1 sequences of 4 FDJS03
isolates showed low identities with the HEV-A, HEV-C,
and HEV-D enterovirus species. Identity scores for
FDJS03 and other isolates with HEV-B were <70% and
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respectively, except with echovirus 30 strains. According
to proposed molecular typing criteria (1), the limits of
intraserotypic divergence should be <25% nucleotide
sequence differences or <12% amino acid sequence differ-
ences. FDJS03 isolates are clustered as echovirus 30 since
they share high identities of both nucleotide (82%) and
amino acid (92%) sequences with the prototype echovirus
30 Bastianni strain. This finding is in agreement with the
results of the serotyping tests.
To investigate the genetic relationships between
FDJS03 isolates and other echovirus 30 isolates from dif-
ferent regions and periods, a phylogenetic analysis was
conducted on complete VP1 nucleotide sequences
(Figure). The tree constructed by the neighbor-joining
method is highly similar to that produced by maximum
parsimony method (data not shown). According to the
bootstrapping support values, echovirus 30 sequences seg-
regate into 3 distinct groups (bootstrap value >80%), with
some temporal and regional subclustering, similar to that
in a previous study (9). FDJS03 isolates were monophylet-
ic and closely related to each other, which suggests a com-
mon origin (bootstrap value 95). Sequences of FDJS03
isolates grouped in subgroup 3c together with those from
Europe and America isolated in the 1970s and 1980s.
Subgroup 3b was composed of viruses isolated between
1990 and 1998 in Europe and North America. In addition,
subgroup 3a contained virus isolated from Japan in 1998
and those from an aseptic meningitis outbreak in Taiwan in
2001 that shared the same genotype with the other 2 sub-
groups, as observed in other studies (18,19). The prototype
strain Bastianni and strains isolated before 1977 were dis-
tributed in 2 distinct genotypes (groups 1 and 2), which
may have become extinct in recent years (9,18).
Discussion
Echovirus 30 is one of the most frequently isolated
enteroviral serotypes that causes aseptic meningitis.
Numerous outbreaks of aseptic meningitis caused by
echovirus 30 have been reported during the last decade in
many countries (20–24). In the spring and summer of
2003, an aseptic meningitis outbreak occurred in the north-
ern part of Jiangsu Province in China. Results of the pres-
ent study show that a distinct lineage of echovirus 30 is
likely responsible for this outbreak. In most cases, knowl-
edge of a specific type of echovirus strain does not con-
tribute to the management of patients. However, in large
outbreaks, identifying enteroviral isolates from patient
specimens should be of epidemiologic importance. 
Enterovirus can be transmitted rapidly and may have
caused worldwide infections (25). However, surveillance
data for enterovirus are incomplete because of the volun-
tary nature of reporting and because only a small number
of enteroviral isolates have been typed (9). The situation is
much worse in many developing countries such as China.
The number of reported outbreaks in China caused by non-
polio enteroviruses has increased in recent years, perhaps
due to better surveillance (26), but little information is
available for these viruses. The temporal dynamics and
genetic diversity among strains of the echovirus 30
serotype have been reported in previous studies (1,9,27),
but no echovirus isolates from China were included. The
present study is the first to show that a distinct lineage of
echovirus 30 caused meningitis in China. This finding is an
important addition to the worldwide echovirus 30 informa-
tion database.
In the present study, CSF specimens were obtained
from only a small number of patients. These specimens
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Figure. Phylogenetic tree based on complete VP1 sequences
among FDJS03 isolates and other strains of echovirus 30 from dif-
ferent geographic and temporal origins. The neighbor-joining
method was used to construct the tree. Numbers at the nodes rep-
resent the percentage of 100 bootstrap pseudoreplicates that con-
tained clusters distal to the node. Prototype strain Farina of
echovirus 21 (shown as E21) was included as the outgroup, but
the tree is unrooted.were then tested by cell culture, largely because of logistic
difficulties encountered since the peak period of this out-
break overlapped that of the epidemic of severe acute res-
piratory syndrome. We obtained a considerable number of
echovirus 30 isolates, but no other serotypes of
enterovirus. This finding strongly suggests that echovirus
30 was the etiologic agent in this outbreak. 
The distinct lineage of echovirus 30 reported in this
outbreak is not surprising, given that genomes of
enteroviruses are known to evolve by ≈1%–2% per year
(28–30), and interserotypic recombination contributes to
evolution of these viruses (31–33).  The FDJS03 isolates
may represent possible recombinants between echovirus
30 and other serotypic enteroviruses. However, large anti-
genic variations in FDJS03 isolates were not observed,
since they could be neutralized by standard antibodies to
echovirus 30. A more detailed determination will require
the complete sequencing of viral genome.
Phylogenetic analysis based on complete sequences of
VP1 genes showed that FDJS03 isolates are closely relat-
ed to each other, with an overall variation <1%. This find-
ing indicates that this outbreak originated from a single
genotype of echovirus 30. Unexpectedly, FDJS03 isolates
are more closely related to echovirus 30 strains prevalent
in Europe and North America than to those circulating in
Japan and Taiwan. Group 3 echoviruses have been isolat-
ed in different areas of 3 continents, demonstrating the
potential of this viral lineage to be transmitted over a large
geographic region. Similarly, the temporal dynamics of
echovirus 30 were seen both in Europe and North America,
but until now no study reported the corresponding dynam-
ics in Asia. Although we used 4 isolates from China and 3
from Japan and Taiwan in the phylogenetic analysis, this
method is not sufficient to determine the overall genetic
diversity and molecular dynamics of echovirus 30 in Asia.
Nevertheless, pairwise comparison of nucleotide
sequences and phylogenetic tree analysis demonstrated
that the VP1 sequences of FDJS03 isolates exist in a sub-
cluster composed of sequences from viruses isolated in
North America in the early 1980s. However, these affini-
ties seem less closely related between FDJS03 isolates and
those circulating during the 1990s. Unfortunately, insuffi-
cient data are available to make definitive conclusions
about defining characteristics of echovirus 30 in China and
elsewhere.
In conclusion, we have characterized a distinct lineage
of echovirus 30 strains isolated from CSF specimens of
aseptic meningitis patients, which appears to be responsi-
ble for an outbreak in the northern area of Jiangsu Province
in China in 2003. The VP1 sequences from these isolates
are most similar to those of echovirus 30 strains that were
common in North America in the early 1980s. This report
is the first of the molecular characteristics of echovirus 30
strains circulating in mainland China and their respective
phylogenetic relationships. However, we could not provide
a comprehensive description of the genetic diversity and
dynamics of echovirus 30 in China or Asia. Thus, estab-
lishing an enterovirus molecular surveillance system is
needed in China to provide a better understanding of virus
transmission and evolution.
Acknowledgments
We thank the prefectural hospitals in Yancheng City, Jiangsu
Province, for providing clinical samples, and the Military
Medical Science Institute, Tianjin, China, for providing the refer-
ence strain of coxsackievirus B1. We also thank Professor Biao
Xu for helpful comments and critical reading of the manuscript,
and Steven Park for helpful advice.
This work was supported by grants from the emergency pro-
ject of the Ministry of Health of the People’s Republic of China.
Dr. Zhao is a PhD candidate at Funan University and spe-
cializes in the epidemiology of infectious diseases.
References
1. Oberste MS, Maher K, Kilpatrick DR, Pallansch MA. Molecular evo-
lution of the human enteroviruses: correlation of serotype with VP1
sequence and application to picornavirus classification. J Virol.
1999;73:1941–8.
2. Reeves WC, Quiroz E, Brenes MM, Centeno R, Campos G. Aseptic
meningitis due to echovirus 4 in Panama City, Republic of Panama.
Am J Epidemiol. 1987;125:562–75.
3.  Amvrosieva TV, Titov LP, Mulders M, Hovi T, Dyakonova OV,
Votyakov VI, et al. Viral water contamination as the cause of aseptic
meningitis outbreak in Belarus. Cent Eur J Public Health.
2001;9:154–7.
4. Meqdam MM, Khalousi MM, Al-Shurman A. Enteroviral meningitis
in northern Jordan: prevalence and association with clinical findings.
J Med Virol. 2002;66:224–8.
5. Peigue-Lafeuille H, Croquez N, Laurichesse H, Clavelou P, Aumaitre
O, Schmidt J, et al. Enterovirus meningitis in adults in 1999–2000
and evaluation of clinical management. J Med Virol. 2002;67:47–53.
6.  Wang DM, Zhao GC, Zhuang SM, Zhang YC. An epidemic of
encephalitis and meningoencephalitis in children caused by echovirus
type 30 in Shanghai. Chin Med J (Engl). 1993;106:767–9.
7. Xu Y, Zhaori G, Vene S, Shen K, Zhou Y, Magnius LO, et al. Viral eti-
ology of acute childhood encephalitis in Beijing diagnosed by analy-
sis of single samples. Pediatr Infect Dis J. 1996;15:1018–24.
8. Deaths among children during an outbreak of hand, foot, and mouth
disease–Taiwan, Republic of China, April–July 1998. MMWR Morb
Mortal Wkly Rep. 1998;47:629–32.
9. Oberste MS, Maher K, Kennett ML, Campbell JJ, Carpenter MS,
Schnurr D, et al. Molecular epidemiology and genetic diversity of
echovirus type 30 (E 30) genotypes correlate with temporal dynam-
ics of E30 isolation. J Clin Microbiol. 1999;37:3928–33.
10. Rezig D, Ben Yahia A, Ben Abdallah H, Bahri O, Triki H. Molecular
characterization of coxsackievirus B5 isolates. J Med Virol.
2004;72:268–74.
11. Grandien M, Forsgren M, Ehrnst A. Enteroviruses and reoviruses. In:
Schmidt NJ, Emmons RW, editors. Diagnostic procedures for viral,
rickettsial and chlamydial infections. 6th ed. Washington: American
Public Health Association; 1989. p. 513–69.
RESEARCH
566 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 4, April 200512. Zoll GJ, Melchers WJ, Kopecka H, Jambroes G, van der Poel HJ,
Galama JM. General primer-mediated polymerase chain reaction for
detection of enteroviruses: application for diagnostic routine and per-
sistent infections. J Clin Microbiol. 1992;30:160–5.
13. Siafakas N, Georgopoulou A, Markoulatos P, Spyrou N, Stanway G.
Molecular detection and identification of an enterovirus during an
outbreak of aseptic meningitis. J Clin Lab Anal. 2001;15:87–95.
14.  Siafakas N, Markoulatos P, Stanway G, Tzanakaki G, Kourea-
Kremastinou J. A reliable RT-PCR/RFLP assay for the molecular
classification of enterovirus reference and wild type strains to either
of the two genetic clusters on the basis of 5'-UTR. Mol Cell Probes.
2002;16:209–16.
15. Siafakas N, Markoulatos P, Vlachos C, Stanway G, Tzanakaki G,
Kourea-Kremastinou J. Molecular sub-grouping of enterovirus refer-
ence and wild type strains into distinct genetic clusters using a sim-
ple RFLP assay. Mol Cell Probes. 2003;17:113–23.
16. Hsiung GD. Picornaviridae. In: Hsiung GD, Fong CKY, Landry ML,
editors. Hsiung’s diagnostic virology. 4th ed. New Haven (CT): Yale
University Press; 1994. p.119–40.
17. Rivera VM, Welsh JD, Maizel JV Jr. Comparative sequence analysis
of the 5' noncoding region of the enteroviruses and rhinoviruses.
Virology. 1988;165:42–50.
18. Savolainen C, Hovi T, Mulders MN. Molecular epidemiology of
echovirus 30 in Europe: succession of dominant sublineages within a
single major genotype. Arch Virol. 2001;146:521–37.
19. Wang JR, Tsai HP, Huang SW, Kuo PH, Kiang D, Liu CC. Laboratory
diagnosis and genetic analysis of an echovirus 30–associated out-
break of aseptic meningitis in Taiwan in 2001. J Clin Microbiol.
2002;40:4439–44.
20. Helfand RF, Khan AS, Pallansch MA, Alexander JP, Meyers HB,
DeSantis RA, et al. Echovirus 30 infection and aseptic meningitis in
parents of children attending a child care center. J Infect Dis.
1994;169:1133–7.
21. Trallero G, Casas I, Tenorio A, Echevarria JE, Castellanos A, Lozano
A, et al. Enteroviruses in Spain: virological and epidemiological stud-
ies over 10 years (1988–97). Epidemiol Infect. 2000,124:497–506.
22. Charrel RN, Bernit E, Zandotti C, de Lamballerie X. An approach
based on RFLPassay to investigate outbreaks of enteroviral meningi-
tis. J Clin Virol. 2004;29:54–8.
23. Uysal G, Ozkaya E, Guven A. Echovirus 30 outbreak of aseptic
meningitis in Turkey. Pediatr Infect Dis J. 2000;19:490.
24. Reintjes R, Pohle M, Vieth U, Lyytikainen O, Timm H, Schreier E, et
al. Community-wide outbreak of enteroviral illness caused by
echovirus 30: a cross-sectional survey and a case-control study.
Pediatr Infect Dis J. 1999;18:104–8.
25. Bailly JL, Brosson D, Archimbaud C, Chambon M, Henquell C,
Peigue-Lafeuille H. Genetic diversity of echovirus 30 during a
meningitis outbreak, demonstrated by direct molecular typing from
cerebrospinal fluid. J Med Virol. 2002;68:558–67.
26. Xie R, Xiang X. Detection of viral aetiology in cerebral spinal fluid
samples from 580 clinical cases. Zhonghua Shi Yan He Lin Chuang
Bing Du Xue Za Zhi. 2000;14:373–5.
27. Palacios G, Casas I, Cisterna D, Trallero G, Tenorio A, Freire C.
Molecular epidemiology of echovirus 30: temporal circulation and
prevalence of single lineages. J Virol. 2002;76:4940–9.
28. Takeda N, Tanimura M, Miyamura K. Molecular evolution of the
major capsid protein VP1 of enterovirus 70. J Virol. 1994;68:854–62.
29. Ishiko H, Takeda N, Miyamura K, Kato N, Tanimura M, Lin KH, et
al. Phylogenetic analysis of a coxsackievirus A24 variant: the most
recent worldwide pandemic was caused by progenies of a virus
prevalent around 1981. Virology. 1992;187:748–59.
30. Rico-Hesse R, Pallansch MA, Nottay BK, Kew OM. Geographic dis-
tribution of wild poliovirus type 1 genotypes. Virology.
1987;160:311–22.
31. Brown B, Oberste MS, Maher K, Pallansch MA. Complete genomic
sequencing shows that polioviruses and members of human
enterovirus species C are closely related in the noncapsid coding
region. J Virol. 2003;77:8973–84.
32. Oberste MS, Maher K, Pallansch MA. Evidence for frequent recom-
bination within species human enterovirus B based on complete
genomic sequences of all thirty-seven serotypes. J Virol.
2004;78:855–67.
33. Oberste MS, Penaranda S, Pallansch MA. RNA recombination plays
a major role in genomic change during circulation of coxsackie B
viruses. J Virol. 2004;78:2948–55. 
Address for correspondence: Qing Wu Jiang, Department of
Epidemiology, School of Public Health, Fudan University, 138 Yi
XueYuan Road, Shanghai, 200032, China; fax: 86-21-6403-7350; email:
qwjiang@shmu.edu.cn
Echovirus 30, Jiangsu Province, China
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 11, No. 4, April 2005 567
The editors of Emerging Infectious Diseases seek
to increase the roster of reviewers for manuscripts
submitted by authors all over the world for publica-
tion in the journal. If you are interested in reviewing
articles on emerging infectious disease topics, please
e-mail your name, address, curriculum vitae, and
areas of expertise to eideditor@ cdc.gov 
At Emerging Infectious Diseases, we always
request reviewers’ consent before sending manu-
scripts, limit review requests to three or four per year,
and allow 2–4 weeks for completion of reviews. We
consider reviewers invaluable in the process of
selecting and publishing high-quality scientific arti-
cles and acknowledge their contributions in the jour-
nal once a year. 
Even though it brings no financial compensation,
participation in the peer-review process is not with-
out rewards. Manuscript review provides scientists at
all stages of their career opportunities for profession-
al growth by familiarizing them with research trends
and the latest work in the field of infectious diseases
and by improving their own skills for presenting sci-
entific information through constructive criticism of
those of their peers. To view the spectrum of articles
we publish, information for authors, and our exten-
sive style guide, visit the journal web site at
www.cdc.gov/eid.
For more information on participating in the peer-
review process of Emerging Infectious Diseases,
email eideditor@ cdc.gov or call the journal office at
404-371-5329.
OPPORTUNITIES FOR PEER REVIEWERS